Home/Filings/4/0000950170-24-002116
4//SEC Filing

Clark David Michael 4

Accession 0000950170-24-002116

CIK 0001178879other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 6:26 PM ET

Size

9.8 KB

Accession

0000950170-24-002116

Insider Transaction Report

Form 4
Period: 2024-01-02
Clark David Michael
Chief People Officer
Transactions
  • Tax Payment

    Common Stock

    2024-01-02$14.24/sh6,331$90,153291,157 total
  • Award

    Stock Options (right to buy)

    2024-01-02+83,22183,221 total
    Exercise: $14.24Exp: 2034-01-02Common Stock (83,221 underlying)
  • Award

    Common Stock

    2024-01-02+48,209297,488 total
  • Tax Payment

    Common Stock

    2024-01-03$13.53/sh11,650$157,625279,507 total
Footnotes (2)
  • [F1]Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on January 2, 2025 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
  • [F2]These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.

Documents

1 file

Issuer

AMICUS THERAPEUTICS, INC.

CIK 0001178879

Entity typeother

Related Parties

1
  • filerCIK 0001755662

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 6:26 PM ET
Size
9.8 KB